Skip to content

How long can compounded tirzepatide be out of the fridge?

Updated November 4, 2026By the Medication Interaction Checker editorial teamHow we check

Quick answer

There is no FDA-set time limit for compounded tirzepatide out of the fridge, so follow the storage directions and beyond-use date on your pharmacy’s label. Compounded versions are not FDA approved, so the 21-day room temperature rule for Mounjaro and Zepbound does not automatically apply. If the label gives no limit, keep it refrigerated and ask the pharmacy.

Medicine vial in a fridge, showing how long compounded tirzepatide can be out of the fridge
Photo: Ivan S / Pexels

How long compounded tirzepatide can be out of the fridge depends on who made it. Brand-name tirzepatide (Mounjaro, Zepbound) has FDA-approved storage limits. A compounded vial has only what the pharmacy wrote on its label.

How Long Can Compounded Tirzepatide Be Out of the Fridge?

Only as long as your compounding pharmacy’s label says. No FDA label covers compounded tirzepatide, so no official room temperature window exists.

The FDA says injectable GLP-1 drugs need refrigeration as stated in their package inserts. For a compounded product, that means the pharmacy’s own label. Check it for:

  • the storage temperature
  • whether any time at room temperature is allowed
  • the beyond-use date, the last day you can use the vial

If any of these is missing, call the pharmacy before your next dose. Until then, keep the vial in the fridge, away from the freezer and out of light.

Does the 21-Day Rule for Mounjaro and Zepbound Apply?

No. The 21-day and 30-day limits are written into the Mounjaro and Zepbound labels and apply only to those products. A compounded vial may use different ingredients, strengths and preservatives.

Section 16.2 of the Zepbound label on DailyMed says the single-dose pen or vial “can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days.” See how we check interactions for how we use FDA labels.

Product Fridge storage Time allowed out of the fridge
Mounjaro or Zepbound single-dose pen or vial 36°F to 46°F Up to 21 days total, at or below 86°F
Mounjaro or Zepbound multi-dose vial or KwikPen 36°F to 46°F 30 days at room temperature, 30 days after first use, or 4 weekly doses, whichever comes first
Compounded tirzepatide vial As stated on the pharmacy label Only what the pharmacy label allows. No FDA-approved limit exists.

Both brand labels (section 16.2) also say: do not freeze, do not use if frozen, and protect from heat and light. For more on the brand-name pens, see how long Zepbound can be out of the fridge.

What If Your Vial Arrived Warm or Was Left Out?

Do not use it until you check with the pharmacy. The FDA advises that patients “not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration.”

Insulated shipping box with ice packs for compounded tirzepatide delivery
Photo: SHVETS production / Pexels

The FDA has received complaints of compounded GLP-1 drugs arriving warm or with too few ice packs. If this happens, contact the pharmacy or telehealth company for a replacement. If a vial was left out at home, only the pharmacy can tell you whether its product is still usable.

Multi-dose vials have a second limit. The FDA recommends using multi-dose vials of sterile medicine within 28 days after first use, because of contamination risk, even if medicine is left.

Example: tracking a 28-day multi-dose vial

  1. Day 1First dose drawn. Write the date on the vial.
  2. Day 8Second weekly dose
  3. Day 15Third weekly dose
  4. Day 22Fourth weekly dose
  5. Day 29Throw the vial away, even if medicine is left

What Are the Main Concerns With Tirzepatide?

The main concerns are stomach side effects, pancreatitis, gallbladder problems, a possible thyroid tumor risk, and dosing mistakes with compounded vials. These warnings come from the brand labels and apply to the same active ingredient.

  • Thyroid tumors. Both labels carry a Boxed Warning. Tirzepatide caused thyroid C-cell tumors in rats. It is not known whether it does this in people. Do not use it if you or your family have had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
  • Pancreatitis. Section 5.5 lists severe stomach pain that may spread to your back, with or without vomiting.
  • Other serious warnings. Section 5 also lists severe stomach and bowel problems, kidney injury from dehydration, gallbladder disease, low blood sugar, and allergic reactions.
  • Birth control pills. The Medication Guide says pills by mouth may not work as well. Your prescriber may suggest another method for 4 weeks after you start and after each dose increase. See birth control pill interactions.
  • Surgery. Tell your surgical team you use tirzepatide, because of a risk of breathing food into the lungs under anesthesia (section 5.9).

Compounded products add their own concerns. The FDA does not review them for safety, effectiveness or quality, and it has received reports of dosing errors when people measured their own doses. Check every medicine you take on our tirzepatide interactions page.

When Should You Talk to a Doctor About Tirzepatide?

Talk to your prescriber before you start, before any dose change, and whenever side effects are new or getting worse.

The Zepbound Medication Guide asks you to tell your provider if you are pregnant or planning pregnancy, breastfeeding, have had pancreas problems, have diabetic eye disease, or have slow stomach emptying (gastroparesis). It also states that it is not known if Zepbound is safe and effective in children. If you take insulin or a sulfonylurea such as glipizide, ask about your low blood sugar risk. For storage questions, call the compounding pharmacy that made your vial.

When to Get Help

Call your doctor or pharmacist if

  • your vial arrived warm, was left out, or was frozen
  • your label has no storage directions or beyond-use date
  • you are unsure how many units to draw for your dose
  • nausea, vomiting or diarrhea will not stop, or you cannot keep fluids down
  • you notice a neck lump, hoarseness or trouble swallowing

Call 911 or Poison Control (1-800-222-1222) right away if

  • you injected far more than your prescribed dose
  • you have severe stomach pain that spreads to your back
  • you have swelling of the face, lips, tongue or throat, or trouble breathing
  • you have signs of very low blood sugar, such as confusion, shaking or fainting

Frequently asked questions

Should compounded tirzepatide be cloudy?

Brand tirzepatide should not be cloudy. Its Instructions for Use say the medicine should be colorless to slightly yellow, with no particles. A compounded vial may differ, so check your pharmacy’s label, and call the pharmacy before injecting anything that looks cloudy or discolored.

Can I freeze compounded tirzepatide?

No. Both brand labels say tirzepatide should not be frozen and should not be used if frozen. If your compounded vial froze by accident, do not inject it until you have spoken to the pharmacy that made it.

What temperature should compounded tirzepatide be stored at?

Use the temperature printed on your pharmacy label. For comparison, the brand labels (section 16.2) say to refrigerate at 36°F to 46°F (2°C to 8°C).

Is compounded tirzepatide the same as Mounjaro or Zepbound?

It has the same active ingredient but is not FDA approved. The FDA declared the tirzepatide injection shortage resolved in December 2024. Ask your prescriber whether an approved product is right for you. You can also read about drinking alcohol on tirzepatide.

Check your combination

Using tirzepatide with other medicines? Check them all in our free interaction checker.

Open the checker

This information is for education and is not medical advice. Do not start, stop or change a medicine without talking to your doctor or pharmacist.